130 related articles for article (PubMed ID: 28850528)
21. Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis.
Reginster JY; Malmstrom K; Mehta A; Bergman G; Ko AT; Curtis SP; Reicin AS
Ann Rheum Dis; 2007 Jul; 66(7):945-51. PubMed ID: 17142385
[TBL] [Abstract][Full Text] [Related]
22. A randomised, double-blinded study comparing giving etoricoxib vs. placebo to female patients with fibromyalgia.
Mahagna H; Amital D; Amital H
Int J Clin Pract; 2016 Feb; 70(2):163-70. PubMed ID: 26763773
[TBL] [Abstract][Full Text] [Related]
23. Early response to COX-2 inhibitors as a predictor of overall response in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib and placebo.
Bingham CO; Smugar SS; Wang H; Tershakovec AM
Rheumatology (Oxford); 2009 Sep; 48(9):1122-7. PubMed ID: 19589894
[TBL] [Abstract][Full Text] [Related]
24. Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis.
Gottesdiener K; Schnitzer T; Fisher C; Bockow B; Markenson J; Ko A; DeTora L; Curtis S; Geissler L; Gertz BJ;
Rheumatology (Oxford); 2002 Sep; 41(9):1052-61. PubMed ID: 12209041
[TBL] [Abstract][Full Text] [Related]
25. Clinical meaningfulness of duloxetine's effect in Chinese patients with chronic pain due to osteoarthritis: post hoc analyses of a phase 3 randomized trial.
Yue L; Luo S; Wang Y; Wang CN; Dueñas HJ; Skljarevski V
Open Access Rheumatol; 2019; 11():67-76. PubMed ID: 30962729
[TBL] [Abstract][Full Text] [Related]
26. The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis.
Myers J; Wielage RC; Han B; Price K; Gahn J; Paget MA; Happich M
BMC Musculoskelet Disord; 2014 Mar; 15():76. PubMed ID: 24618328
[TBL] [Abstract][Full Text] [Related]
27. Low-dose SoluMatrix diclofenac in patients with osteoarthritis pain: impact on quality of life in a controlled trial.
Strand V; Bergman M; Singh JA; Gibofsky A; Kivitz A; Young C
Clin Rheumatol; 2017 Jun; 36(6):1357-1367. PubMed ID: 28194525
[TBL] [Abstract][Full Text] [Related]
28. Steroid injection for osteoarthritis of the hip: a randomized, double-blind, placebo-controlled trial.
Lambert RG; Hutchings EJ; Grace MG; Jhangri GS; Conner-Spady B; Maksymowych WP
Arthritis Rheum; 2007 Jul; 56(7):2278-87. PubMed ID: 17599747
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of duloxetine by prior NSAID use in the treatment of chronic osteoarthritis knee pain: A post hoc subgroup analysis of a randomized, placebo-controlled, phase 3 study in Japan.
Enomoto H; Fujikoshi S; Tsuji T; Sasaki N; Tokuoka H; Uchio Y
J Orthop Sci; 2018 Nov; 23(6):1019-1026. PubMed ID: 30126675
[TBL] [Abstract][Full Text] [Related]
30. Responsiveness of the electronic touch screen WOMAC 3.1 OA Index in a short term clinical trial with rofecoxib.
Theiler R; Bischoff-Ferrari HA; Good M; Bellamy N
Osteoarthritis Cartilage; 2004 Nov; 12(11):912-6. PubMed ID: 15501407
[TBL] [Abstract][Full Text] [Related]
31. A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis.
Balazcs E; Sieper J; Bickham K; Mehta A; Frontera N; Stryszak P; Popmihajlov Z; Peloso PM
BMC Musculoskelet Disord; 2016 Oct; 17(1):426. PubMed ID: 27737664
[TBL] [Abstract][Full Text] [Related]
32. Discriminant validity of the Western Ontario and McMaster Universities Osteoarthritis index physical functioning subscale in community samples with hip osteoarthritis.
Pua YH; Cowan SM; Wrigley TV; Bennell KL
Arch Phys Med Rehabil; 2009 Oct; 90(10):1772-7. PubMed ID: 19801070
[TBL] [Abstract][Full Text] [Related]
33. Lorecivivint, a Novel Intraarticular CDC-like Kinase 2 and Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial.
Yazici Y; McAlindon TE; Gibofsky A; Lane NE; Clauw D; Jones M; Bergfeld J; Swearingen CJ; DiFrancesco A; Simsek I; Tambiah J; Hochberg MC
Arthritis Rheumatol; 2020 Oct; 72(10):1694-1706. PubMed ID: 32432388
[TBL] [Abstract][Full Text] [Related]
34. Pain management after elective hallux valgus surgery: a prospective randomized double-blind study comparing etoricoxib and tramadol.
Brattwall M; Turan I; Jakobsson J
Anesth Analg; 2010 Aug; 111(2):544-9. PubMed ID: 20584877
[TBL] [Abstract][Full Text] [Related]
35. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis.
Ehrich EW; Davies GM; Watson DJ; Bolognese JA; Seidenberg BC; Bellamy N
J Rheumatol; 2000 Nov; 27(11):2635-41. PubMed ID: 11093446
[TBL] [Abstract][Full Text] [Related]
36. Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib.
Holt RJ; Fort JG; Grahn AY; Kent JD; Bello AE
Phys Sportsmed; 2015 Jul; 43(3):200-12. PubMed ID: 26313454
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: A randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial.
Leung AT; Malmstrom K; Gallacher AE; Sarembock B; Poor G; Beaulieu A; Castro R; Sanchez M; Detora LM; Ng J
Curr Med Res Opin; 2002; 18(2):49-58. PubMed ID: 12017209
[TBL] [Abstract][Full Text] [Related]
38. Comparison of measurement properties of the P4 pain scale and disease specific pain measures in patients with knee osteoarthritis.
Robbins SM; Rastogi R; Howard J; Rosedale R
Osteoarthritis Cartilage; 2014 Jun; 22(6):805-12. PubMed ID: 24721460
[TBL] [Abstract][Full Text] [Related]
39. Effect of physical therapy on pain and function in patients with hip osteoarthritis: a randomized clinical trial.
Bennell KL; Egerton T; Martin J; Abbott JH; Metcalf B; McManus F; Sims K; Pua YH; Wrigley TV; Forbes A; Smith C; Harris A; Buchbinder R
JAMA; 2014 May; 311(19):1987-97. PubMed ID: 24846036
[TBL] [Abstract][Full Text] [Related]
40. Effect of rofecoxib therapy on measures of health-related quality of life in patients with osteoarthritis.
Ehrich EW; Bolognese JA; Watson DJ; Kong SX
Am J Manag Care; 2001 Jun; 7(6):609-16. PubMed ID: 11439734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
